INNOVACAP Innova Captab Q4 FY26 results (Jan–Mar 2026) and concall
Innova Captab delivered strong Q4 and FY26 results, achieving its highest-ever annual performance with significant revenue growth across both CDMO and Branded Generics segments. The Jammu facility is nearing profitability, and the company has strategic capex plans for a new Baddi facility to support future growth. While product mix impacted Q4 margins, management expects overall margin expansion and outperformance of PAT growth over EBITDA growth in the coming fiscal year.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 42.2%, net profit up 26.7% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 318 | 316 | 315 | 352 | 380 +19% | 450 +42% | 448 +42% |
| EBITDA | 50 | 47 | 48 | 52 | 52 +4% | 69 +47% | 65 +35% |
| Net profit | 35 | 34 | 30 | 31 | 30 −14% | 42 +24% | 38 +27% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
